ANDOVER, Mass.--(BUSINESS WIRE)--Diomed Holdings, Inc. (AMEX: DIO), a leading developer and marketer of minimally invasive medical technologies, including its patented EndoVenous Laser Treatment (EVLT(R)) for varicose veins, today announced that it has entered into a $10 million senior secured term loan with Hercules Technology Growth Capital, Inc., effectively monetizing the damages award arising out of its ‘777 patent litigation.
